Papavasileiou Lida Pieretta, Santini Luca, Forleo Giovanni B, Ammirati Fabrizio, Santini Massimo
a Electrophysiology, Pacemaker and ICD Unit , Diagnostic and Therapeutic Centre of Athens - Hygeia , Athens , Greece.
b Cardiology Department , Fondazione PTV Policlinico Tor Vergata , Roma , Italy.
Expert Rev Cardiovasc Ther. 2016 Aug;14(8):905-13. doi: 10.1080/14779072.2016.1187064. Epub 2016 May 28.
Approximately 1-2% of the adult population in developed countries is affected by heart failure. The costs of heart failure are enormous both in Europe and in the US and are expected to rise. New technologies and remote monitoring, are valid tools for the management and treatment of these patients.
This review aims to cover both implantable and non-implantable devices available for monitoring various hemodynamic parameters and clinical features of patients, as well as algorithms implemented in the new generation ICDs and CRTs capable of simultaneous acquisition and transmission of multiple parameters that indirectly evaluate clinical and/or hemodynamic status. Both internet and PubMed searches were used in order to acquire the most recent developments in the technology of the field. Expert commentary: As new technology offers an enormous data flow, the key for success in the battle against heart failure and related hospitalizations is understanding the correct way of utilizing the data acquired and their importance for the treatment of each individual person.
在发达国家，约1%-2%的成年人口受心力衰竭影响。心力衰竭在欧洲和美国的花费都十分巨大，且预计还会上升。新技术和远程监测是管理和治疗这些患者的有效工具。
本综述旨在涵盖可用于监测患者各种血流动力学参数和临床特征的植入式和非植入式设备，以及新一代植入式心脏复律除颤器（ICD）和心脏再同步治疗（CRT）中实施的算法，这些算法能够同时采集和传输多个参数，间接评估临床和/或血流动力学状态。为获取该领域技术的最新进展，我们同时进行了互联网搜索和PubMed搜索。专家评论：由于新技术提供了海量的数据流，在对抗心力衰竭及相关住院治疗的战斗中取得成功的关键在于理解正确利用所采集数据的方法及其对每个个体治疗的重要性。
